[Skip to Content]
[Skip to Content Landing]

A Middle-aged Woman With Recurrent Chest Pain With Troponin Elevation and Unobstructed Coronary Arteries

Educational Objective
Based on this clinical scenario and the accompanying image, understand how to arrive at a correct diagnosis.
1 Credit CME

A middle-aged woman presented with chest pain, elevated troponin-T of 1037 ng/L (normal <14 ng/L; to convert to micrograms per liter, multiply by 1), and anterior T-wave inversion on electrocardiography. She was a smoker with hypertension and kidney dysfunction, with a history of left-sided paresthesia.

Coronary angiography demonstrated unobstructed coronary arteries. Cardiovascular magnetic resonance (CMR) imaging revealed subendocardial midinferolateral late gadolinium enhancement with corresponding hypokinesis consistent with a partial-thickness myocardial infarction. Prolonged Holter monitoring showed no evidence of atrial fibrillation.

Please finish quiz first before checking answer.

You answered correctly!

Read the answer below and download your certificate.

You answered incorrectly.

Read the discussion below and retake the quiz.

A middle-aged woman presented with chest pain, elevated troponin-T of 1037 ng/L (normal <14 ng/L; to convert to micrograms per liter, multiply by 1), and anterior T-wave inversion on electrocardiography. She was a smoker with hypertension and kidney dysfunction, with a history of left-sided paresthesia.

Coronary angiography demonstrated unobstructed coronary arteries. Cardiovascular magnetic resonance (CMR) imaging revealed subendocardial midinferolateral late gadolinium enhancement with corresponding hypokinesis consistent with a partial-thickness myocardial infarction. Prolonged Holter monitoring showed no evidence of atrial fibrillation.

Two years later, she had a similar presentation consistent with a non–ST-elevation myocardial infarction. Repeated coronary angiography again demonstrated unobstructed coronary arteries. The CMR revealed the same midinferolateral late gadolinium enhancement as at the initial examination (Figure, A) but with focal enhancement on T2 short tau inversion recovery sequences (Figure, B), with increased T1 and T2 values suggestive of associated edema from an acute infarction in the same territory. A mobile interatrial septum was noted on 4-chamber cine imaging. A transthoracic echocardiogram bubble study demonstrated color flow at rest across the interatrial septum and a large shunt on Valsalva maneuver consistent with a grade 3 patent foramen ovale (PFO) (Video). Coincidentally, a brain MR scan to investigate the recurrent paresthesia revealed bilateral white matter lesions thought to be secondary to small-vessel disease greater in number than expected for the patient’s age, raising suspicion for microemboli.

Survey Complete!

Sign in to take quiz and track your certificates

Buy This Activity

JN Learning™ is the home for CME and MOC from the JAMA Network. Search by specialty or US state and earn AMA PRA Category 1 Credit(s)™ from articles, audio, Clinical Challenges and more. Learn more about CME/MOC

CME Disclosure Statement: Unless noted, all individuals in control of content reported no relevant financial relationships. If applicable, all relevant financial relationships have been mitigated.

Article Information

Corresponding Author: Mohammed Y. Khanji, MBBCh(Hons), PhD Newham University Hospital and Barts Heart Centre, Barts Health NHS Trust, Glen Road, London E13 8SL, England (m.khanji@qmul.ac.uk).

Published Online: March 10, 2021. doi:10.1001/jamacardio.2021.0116

Conflict of Interest Disclosures: None reported.

Additional Contributions: We acknowledge Fizzah Choudhry, MBBS, BSC, MRCP, PhD, of Barts Heart Centre, London, England, who was involved in the patient’s treatment. No compensation was received from a funding source for these contributions.

References
1.
Pristipino  C , Sievert  H , D’Ascenzo  F ,  et al; Evidence Synthesis Team; Eapci Scientific Documents and Initiatives Committee; International Experts.  European position paper on the management of patients with patent foramen ovale. General approach and left circulation thromboembolism.   Eur Heart J. 2019;40(38):3182-3195.PubMedGoogle ScholarCrossref
2.
Mas  J-L , Derumeaux  G , Guillon  B ,  et al; CLOSE Investigators.  Patent foramen ovale closure or anticoagulation vs. antiplatelets after stroke.   N Engl J Med. 2017;377(11):1011-1021. doi:10.1056/NEJMoa1705915PubMedGoogle ScholarCrossref
3.
Saver  JL , Carroll  JD , Thaler  DE ,  et al; RESPECT Investigators.  Long-term outcomes of patent foramen ovale closure or medical therapy after stroke.   N Engl J Med. 2017;377(11):1022-1032. doi:10.1056/NEJMoa1610057PubMedGoogle ScholarCrossref
4.
Lee  PH , Song  J-K , Kim  JS ,  et al.  Cryptogenic stroke and high-risk patent foramen ovale: the DEFENSE-PFO trial.   J Am Coll Cardiol. 2018;71(20):2335-2342. doi:10.1016/j.jacc.2018.02.046PubMedGoogle ScholarCrossref
5.
Mas  JL , Arquizan  C , Lamy  C ,  et al; Patent Foramen Ovale and Atrial Septal Aneurysm Study Group.  Recurrent cerebrovascular events associated with patent foramen ovale, atrial septal aneurysm, or both.   N Engl J Med. 2001;345(24):1740-1746. doi:10.1056/NEJMoa011503PubMedGoogle ScholarCrossref
6.
Turc  G , Calvet  D , Guérin  P , Sroussi  M , Chatellier  G , Mas  J-L ; CLOSE Investigators.  Closure, anticoagulation, or antiplatelet therapy for cryptogenic stroke with patent foramen ovale: systematic review of randomized trials, sequential meta-analysis, and new insights from the CLOSE study.   J Am Heart Assoc. 2018;7(12):e008356. doi:10.1161/JAHA.117.008356PubMedGoogle Scholar
7.
Dao  CN , Tobis  JM .  PFO and paradoxical embolism producing events other than stroke.   Catheter Cardiovasc Interv. 2011;77(6):903-909. doi:10.1002/ccd.22884PubMedGoogle ScholarCrossref
8.
Pristipino  C , Anzola  GP , Ballerini  L ,  et al; Italian Society of Invasive Cardiology (SICI-GISE); Italian Stroke Association (ISA-AIS); Italian Association of Hospital Neurologists, Neuroradiologists, Neurosurgeons (SNO); Congenital Heart Disease Study Group of Italian Society Of Cardiology; Italian Association Of Hospital Cardiologists (ANMCO); Italian Society Of Pediatric Cardiology (SICP); Italian Society of Cardiovascular Echography (SIEC); Italian Society of Hemostasis and Thrombosis (SISET).  Management of patients with patent foramen ovale and cryptogenic stroke: a collaborative, multidisciplinary, position paper.   Catheter Cardiovasc Interv. 2013;82(1):E38-E51. doi:10.1002/ccd.24637PubMedGoogle ScholarCrossref
9.
Collado  FMS , Poulin  M-F , Murphy  JJ , Jneid  H , Kavinsky  CJ .  Patent foramen ovale closure for stroke prevention and other disorders.   J Am Heart Assoc. 2018;7(12):e007146. doi:10.1161/JAHA.117.007146PubMedGoogle Scholar
10.
Kuijpers  T , Spencer  FA , Siemieniuk  RAC ,  et al.  Patent foramen ovale closure, antiplatelet therapy or anticoagulation therapy alone for management of cryptogenic stroke? a clinical practice guideline.   BMJ. 2018;362:k2515. https://www.bmj.com/content/362/bmj.k2515. doi:10.1136/bmj.k2515PubMedGoogle ScholarCrossref
AMA CME Accreditation Information

Credit Designation Statement: The American Medical Association designates this Journal-based CME activity activity for a maximum of 1.00  AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to:

  • 1.00 Medical Knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program;;
  • 1.00 Self-Assessment points in the American Board of Otolaryngology – Head and Neck Surgery’s (ABOHNS) Continuing Certification program;
  • 1.00 MOC points in the American Board of Pediatrics’ (ABP) Maintenance of Certification (MOC) program;
  • 1.00 Lifelong Learning points in the American Board of Pathology’s (ABPath) Continuing Certification program; and
  • 1.00 credit toward the CME [and Self-Assessment requirements] of the American Board of Surgery’s Continuous Certification program

It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting MOC credit.

Close
Want full access to the AMA Ed Hub?
After you sign up for AMA Membership, make sure you sign in or create a Physician account with the AMA in order to access all learning activities on the AMA Ed Hub
Buy this activity
Close
Want full access to the AMA Ed Hub?
After you sign up for AMA Membership, make sure you sign in or create a Physician account with the AMA in order to access all learning activities on the AMA Ed Hub
Buy this activity
Close
With a personal account, you can:
  • Access free activities and track your credits
  • Personalize content alerts
  • Customize your interests
  • Fully personalize your learning experience
Education Center Collection Sign In Modal Right
Close

Name Your Search

Save Search
With a personal account, you can:
  • Access free activities and track your credits
  • Personalize content alerts
  • Customize your interests
  • Fully personalize your learning experience
Close
Close

Lookup An Activity

or

My Saved Searches

You currently have no searches saved.

Close

My Saved Courses

You currently have no courses saved.

Close